# Cigna Group (CI) Q2 2026 earnings

Results filed 2026-07-30 for the quarter ended 2026-06-30. Source page: https://earnings.opennash.com/companies/ci/2026-q2/
Press release and documents: https://www.sec.gov/Archives/edgar/data/1739940/000114036126030135/0001140361-26-030135-index.htm
> Summaries and transcripts are machine-generated and can contain errors.

## In brief

Cigna is exiting Individual and Family Plans from January 2027 while Evernorth's specialty business grows on biosimilar and generic adoption and pharmacy benefit margins absorb large client renewals.

Cigna Healthcare grew medical customers to 18.4 million, led by Middle and Select markets, while National Accounts membership declined. Premium increases drove growth in the employer business, which also saw better margins. At Evernorth, specialty volume was strong, helped by higher generic and biosimilar use that lowers costs for clients and patients. Pharmacy customers fell to 118.2 million on expected client transitions and lower health plan membership.
Management is steering toward technology, data and AI to personalize customer experiences, widen access and cut costs, and is trimming the portfolio by leaving Individual and Family Plans on January 1, 2027. The main tension is in pharmacy benefits, where large client contract renewals and customer-focused initiatives are cutting profit even as revenue grows, while pharmacy membership keeps shrinking.

## Key numbers

| Metric | Value | Change | Basis |
| --- | --- | --- | --- |
| Total revenues | $71.7 billion | up 7% from a year ago | GAAP |
| Shareholders' net income | $1.7 billion |  | GAAP |
| Diluted EPS | $6.29 | compared to $5.71 for second quarter 2025 | GAAP |
| Adjusted income from operations per share | $7.78 | compared with $7.20 for second quarter 2025 | non-GAAP |

## Segments and operating metrics

| Name | Value | Change |
| --- | --- | --- |
| Cigna Healthcare medical care ratio | 84.5% | compared to 83.2% for second quarter 2025 |

## Outlook

| Metric | Period | Outlook |
| --- | --- | --- |
| Adjusted income from operations per share | full year 2026 | at least $30.45 |
| Evernorth adjusted income from operations, pre-tax | full year 2026 | at least $6,900 |
| Cigna Healthcare adjusted income from operations, pre-tax | full year 2026 | at least $4,550 |
| Cigna Healthcare medical care ratio | full year 2026 | 83.7% to 84.7% |

## Key takeaways

1. **Cigna will exit Individual and Family Plans** The company announced in April 2026 that it will leave the Individual and Family Plans medical business as of January 1, 2027. This narrows Cigna Healthcare toward employer-focused markets.
2. **Specialty growth is driven by volume and biosimilars** Specialty and Care Services saw strong specialty volume growth and higher generic and biosimilar adoption, which the company says lowers costs for clients and patients. Pre-tax operating income rose 22%.
3. **Pharmacy benefit profits fall on client renewals** Pharmacy Benefit Services pre-tax income fell 27%, reflecting large client contract renewals and customer-focused initiatives, consistent with prior commentary. Revenue still rose 8% on drug mix.
4. **Medical membership grows in Middle and Select** Total medical customers rose 2% since year-end to 18.4 million, with gains in Middle and Select markets partly offset by lower National Accounts membership.
5. **Pharmacy customer base shrinks on client transitions** Pharmacy customers fell 4% since year-end to 118.2 million, reflecting expected client transitions and lower membership from health plan clients. This leaves the company with fewer pharmacy relationships even as it pursues AI-led personalization.

## Questions

**What is Cigna doing with its Individual and Family Plans business?** Cigna announced in April 2026 that it plans to exit the Individual and Family Plans medical business as of January 1, 2027.
**Why did pharmacy benefit profit fall?** Pharmacy Benefit Services pre-tax income fell 27% because of client-focused initiatives, including large client contract renewals, and customer-focused initiatives, consistent with prior commentary.
**What is driving growth in Cigna's specialty business?** Strong specialty volume growth and organic growth in specialty businesses, including higher generic and biosimilar adoption, drove the segment's results.
**How did Cigna's customer base change this quarter?** Medical customers rose 2% since December 31, 2025 to 18.4 million on Middle and Select market growth, while pharmacy customers fell 4% to 118.2 million.
**Where is Cigna focusing its strategy?** Management said it is using technology, data and AI to deliver more personalized experiences, improve access and lower costs.

## Slides and investor documents

- [Transcript](https://s202.q4cdn.com/757723766/files/doc_earnings/2026/q2/transcript/2Q26-transcript.pdf) (Company's official transcript)
- [Financial Supplement](https://s202.q4cdn.com/757723766/files/doc_earnings/2026/q2/supplemental-info/2Q26-financial-supplement.pdf) (Financial tables)
- [Form 10-Q](https://s202.q4cdn.com/757723766/files/doc_earnings/2026/q2/filing/CI-10Q-Q2-2026.pdf) (Document)

